Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma
Status:
Completed
Trial end date:
2017-12-07
Target enrollment:
Participant gender:
Summary
This local, prospective, multicenter, non-interventional study documents observational data
on patients under routine treatment of metastatic RCC with Nexavar before and after
cytoreductive nephrectomy. It's planned to better understand the impact of cytoreductive
nephrectomy on Nexavar efficacy and possibly to define patients who get the most benefit from
Nexavar before cytoreductive nephrectomy.